Skip to main content
Premium Trial:

Request an Annual Quote

Bruker MALDI-2 Source for TimsTOF Flex; 4D Proteomics Workflows

Bruker has launched the MALDI-2 post-ionization source as an option on its TimsTOF Flex ESI/MALDI mass spectrometer. The new technology can offer one or two orders of magnitude higher sensitivity for many small molecules and lipids, increasing the range of applications of MALDI mass spectrometry and imaging. MALDI-2 requires a second laser (266 nm) fired orthogonally into the expanding MALDI plume that is generated by Bruker's proprietary primary SmartBeam 3D (355 nm) laser. An optimized FlexMatrix formulation is recommended for MALDI-2, the company said.

Bruker has also launched TIMS/PASEF-enabled 4D proteomics methods that leverage the large-scale, real-time availability of accurate collision cross sections for tens of thousands of measured peptides per 4D nanoLC-CCS-MS/MS run. These new methods and software include prm-PASEF, short-gradient dia-PASEF, MOMA, and "run and done" proteomics using a novel GPU-based real-time search engine. The new innovations enable enhanced peptide, protein, and PTM identification; sustained, ultra-high sensitivity LFQ performance; and truly high-throughput methods for 4D proteomics, 4D lipidomics, and 4D metabolomics on the TimsTOF Pro platform, Bruker said.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.